Exact Sciences(EXAS),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

EXAS Exact Sciences

Trading 03-12 10:58:15 EDT

103.32

-0.08

-0.08%

High103.41	Low103.30	Vol269.56K
Open103.37	D1 Closing103.40	Amplitude0.11%
Mkt Cap19.71B	Tradable Cap19.37B	Total Shares190.81M
T/O27.86M	T/O Rate0.14%	Tradable Shares187.46M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"EXAS","market":"US","secType":"STK","nameCN":"Exact Sciences","latestPrice":103.315,"timestamp":1773327486559,"preClose":103.4,"halted":0,"volume":269564,"delay":0,"changeRate":-0.0008220502901354734,"floatShares":187461719,"shares":190810202,"eps":-1.102078,"marketStatus":"Trading","change":-0.085,"latestTime":"03-12 10:58:15 EDT","open":103.37,"high":103.4107,"low":103.3,"amount":27860570.22098,"amplitude":0.001071,"askPrice":103.32,"askSize":357,"bidPrice":103.31,"bidSize":697,"shortable":3,"etf":0,"ttmEps":-1.102078,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1773345600000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":980917200000,"exchange":"NASDAQ","adjPreClose":103.4,"preHourTrading":{"tag":"盘前","latestPrice":103.4,"preClose":103.4,"latestTime":"09:29 EDT","volume":324,"amount":33515.59032,"timestamp":1773322199999,"change":0,"changeRate":0,"amplitude":0.000484},"postHourTrading":{"tag":"盘后","latestPrice":103.51,"preClose":103.4,"latestTime":"19:59 EDT","volume":10368,"amount":1072096.6876,"timestamp":1773273593868,"change":0.11,"changeRate":0.001064,"amplitude":0.001064},"volumeRatio":0.516859,"impliedVol":0.0367,"impliedVolPercentile":0.0279},"requestUrl":"/m/hq/s/EXAS/wiki","defaultTab":"wiki","newsList":[{"id":"2618784674","title":"Abbott Laboratories closes USD 20 billion senior notes offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2618784674","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618784674?lang=en_us&edition=fundamental","pubTime":"2026-03-10 04:22","pubTimestamp":1773087750,"startTime":"0","endTime":"0","summary":"Abbott completed a public offering of USD 20 billion of senior notes. The issuance included USD 1 billion of floating-rate notes due 2029 and USD 19 billion of fixed-rate notes across seven tranches. The fixed-rate tranches ranged from 4% notes due 2031 to 6% notes due 2066. Abbott said it plans to use the net proceeds, along with cash and/or additional borrowings, to fund its planned acquisition of Exact Sciences and related costs. If the Exact Sciences deal is not completed by the specified deadline or Abbott ends pursuit, the company must redeem any notes then outstanding at 101% of principal plus accrued interest.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Abbott Laboratories published the original content used to generate this","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260309:nNDLbCRXW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B2B36J28.USD","LU1721429741.USD","LU2324357040.USD","LU0266013472.USD","LU0058720904.USD","IE0002141913.USD","IE0009355771.USD","SG9999002232.USD","LU2133065610.SGD","LU2112291526.USD","LU0122379950.USD","IE00B4R5TH58.HKD","SGXZ23171101.USD","BK4568","LU2468319806.SGD","LU0882574055.USD","BK4566","EXAS","IE00BJT1NW94.SGD","BK4548","LU1057294990.SGD","LU1989763427.SGD","LU1023059063.AUD","SG9999002224.SGD","LU1691799644.USD","IE00BJJMRZ35.SGD","LU0234572021.USD","LU1989763690.USD","BK4588","BK4504","LU1721429402.USD","LU1061106388.HKD","LU0114720955.EUR","BK4592","LU2237957811.SGD","LU0170899867.USD","SG9999004303.SGD","BK4139","LU1861558580.USD","LU2211815571.USD","LU1861559042.SGD","SGXZ41872573.SGD","ABT","BK4082","LU2237957902.USD","BK4581","IE00BFTCPJ56.SGD","BK4533","LU1914381329.SGD","LU0868494617.USD"],"gpt_icon":0},{"id":"2616321351","title":"Privia Health partners with Amalgam Rx and Exact Sciences on colorectal cancer screening program","url":"https://stock-news.laohu8.com/highlight/detail?id=2616321351","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616321351?lang=en_us&edition=fundamental","pubTime":"2026-03-03 23:00","pubTimestamp":1772550035,"startTime":"0","endTime":"0","summary":"Privia Health Group Inc. partnered with Amalgam Rx, Inc. and Exact Sciences Corp. on a colorectal cancer screening program that integrates clinical decision support and automated patient outreach into the athenaClinicals EHR. The collaboration helped boost Privia’s colorectal cancer screening rate to 84% in 2024, engaging tens of thousands of patients and scaling nationally to reach more than 100,000 people.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Privia Health Group Inc. published the original content used to generate this news brief via Business Wire  on March 03, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260303:nNDL1mMCft:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4581","BK4196","EXAS","LU1861559042.SGD","BK4585","BK4139","BK4588","PRVA","LU1861558580.USD","BK4548","LU2324357040.USD","BK4539","LU0266013472.USD"],"gpt_icon":0},{"id":"2616218753","title":"Marking National Colorectal Cancer Awareness Month, Privia Health Program Achieves 84% Colorectal Cancer Screening Rate Through Industry Collaboration","url":"https://stock-news.laohu8.com/highlight/detail?id=2616218753","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616218753?lang=en_us&edition=fundamental","pubTime":"2026-03-03 23:00","pubTimestamp":1772550002,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260303:nTUA4SMP5G:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4581","LU1861558580.USD","BK4139","EXAS","LU0266013472.USD","BK4585","LU1861559042.SGD","PRVA","BK4196","BK4539","BK4588","BK4548","LU2324357040.USD"],"gpt_icon":0},{"id":"2614071903","title":"Abbott Laboratories launches $20 billion senior notes offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2614071903","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614071903?lang=en_us&edition=fundamental","pubTime":"2026-02-27 05:42","pubTimestamp":1772142169,"startTime":"0","endTime":"0","summary":"Abbott Laboratories entered into a pricing agreement on Feb. 23, 2026 to issue and sell $20.0 billion of senior notes. The offering consists of $1.0 billion of Floating Rate Notes due 2029, plus fixed-rate notes including $2.25 billion of 3.700% notes due 2029, $2.5 billion of 4.000% notes due 2031, $2.75 billion of 4.300% notes due 2033, $3.75 billion of 4.650% notes due 2036, $2.0 billion of 4.750% notes due 2038, $3.75 billion of 5.500% notes due 2056 and $2.0 billion of 5.600% notes due 2066. Closing is expected March 9, 2026, and Abbott said it plans to use proceeds to help fund its planned acquisition of Exact Sciences, repay certain Exact Sciences debt, pay related fees and expenses, and for general corporate purposes.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260226:nNDL4RpMWD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2468319806.SGD","IE00B4R5TH58.HKD","LU1861559042.SGD","SGXZ23171101.USD","BK4139","LU1914381329.SGD","BK4568","IE00B2B36J28.USD","LU1057294990.SGD","LU0122379950.USD","IE00BJT1NW94.SGD","LU0868494617.USD","SGXZ41872573.SGD","ABT","BK4585","LU0882574055.USD","LU2133065610.SGD","LU0170899867.USD","BK4548","IE0009355771.USD","LU2112291526.USD","LU0058720904.USD","LU2211815571.USD","LU1061106388.HKD","LU1721429741.USD","BK4504","BK4581","LU1989763427.SGD","LU1989763690.USD","IE00BJJMRZ35.SGD","BK4592","LU1861558580.USD","EXAS","BK4588","LU1023059063.AUD","LU1691799644.USD","BK4533","LU2089984988.USD","SG9999002224.SGD","LU0234572021.USD","LU2324357040.USD","SG9999002232.USD","SG9999004303.SGD","BK4082","LU0266013472.USD","BK4566","IE00BFTCPJ56.SGD","LU0114720955.EUR","LU1721429402.USD","LU0289739699.SGD"],"gpt_icon":0},{"id":"2613878720","title":"Abbott Laboratories Commences 8-Part Bond Sale Tied to Exact Sciences Acquisition, Bloomberg Reports","url":"https://stock-news.laohu8.com/highlight/detail?id=2613878720","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613878720?lang=en_us&edition=fundamental","pubTime":"2026-02-23 22:01","pubTimestamp":1771855262,"startTime":"0","endTime":"0","summary":"Abbott Laboratories Commences 8-Part Bond Sale Tied to Exact Sciences Acquisition, Bloomberg Reports","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","TMF","IE00BJT1NW94.SGD","LU2211815571.USD","IE00B2B36J28.USD","BK4082","US12M.BOND","BK4548","TLTW","LU0170899867.USD","US30Y.BOND","BK4588","SGXZ41872573.SGD","IE00BJJMRZ35.SGD","LU1057294990.SGD","BK4504","LU1061106388.HKD","IE00B4R5TH58.HKD","LU1989763690.USD","SG9999002224.SGD","BK4592","LU1989763427.SGD","EXAS","US5Y.BOND","IE0009355771.USD","LU0266013472.USD","LU1721429741.USD","LU1861558580.USD","US6M.BOND","LU2468319806.SGD","BK4566","LU1023059063.AUD","LU0882574055.USD","LU2324357040.USD","US3Y.BOND","IE0002141913.USD","LU2133065610.SGD","LU1861559042.SGD","BK4533","LU0234572021.USD","LU0058720904.USD","LU2237957902.USD","US7Y.BOND","US2Y.BOND","ABT","LU0122379950.USD","US10Y.BOND","BK4568","LU0289739699.SGD"],"gpt_icon":0},{"id":"2613218643","title":"BRIEF-Exact Sciences Stockholders Approve Acquisition By Abbott","url":"https://stock-news.laohu8.com/highlight/detail?id=2613218643","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613218643?lang=en_us&edition=fundamental","pubTime":"2026-02-21 06:34","pubTimestamp":1771626853,"startTime":"0","endTime":"0","summary":"BRIEF-Exact Sciences Stockholders Approve Acquisition By AbbottFeb 20 (Reuters) - Exact Sciences Corp EXAS.O:EXACT SCIENCES STOCKHOLDERS APPROVE ACQUISITION BY ABBOTTEXACT SCIENCES CORP - DEAL EXPECTE","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260220:nTUA8THBKS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2468319806.SGD","IE00B4R5TH58.HKD","LU1861559042.SGD","LU2237957811.SGD","SGXZ23171101.USD","BK4139","LU1914381329.SGD","BK4568","IE00B2B36J28.USD","LU1057294990.SGD","LU0122379950.USD","IE00BJT1NW94.SGD","LU0868494617.USD","SGXZ41872573.SGD","ABT","BK4585","LU0882574055.USD","IE0002141913.USD","LU0170899867.USD","BK4548","LU2112291526.USD","LU0058720904.USD","LU2211815571.USD","LU1061106388.HKD","LU1721429741.USD","BK4504","BK4581","LU1989763427.SGD","LU1989763690.USD","IE00BJJMRZ35.SGD","BK4592","LU1861558580.USD","EXAS","LU1023059063.AUD","LU1691799644.USD","LU2089984988.USD","BK4533","SG9999002224.SGD","LU0234572021.USD","LU2324357040.USD","SG9999002232.USD","SG9999004303.SGD","BK4082","LU0266013472.USD","LU2237957902.USD","BK4566","IE00BFTCPJ56.SGD","LU0114720955.EUR","LU1721429402.USD","LU0289739699.SGD"],"gpt_icon":0},{"id":"2613290948","title":"EXACT Sciences Corporation Held Special Stockholder Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2613290948","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613290948?lang=en_us&edition=fundamental","pubTime":"2026-02-21 05:55","pubTimestamp":1771624551,"startTime":"0","endTime":"0","summary":"EXACT Sciences Corporation held a special meeting of stockholders on February 20, 2026. Stockholders approved the proposal to adopt the merger agreement, did not approve the advisory proposal on executive officer merger-related compensation, and approved the proposal to adjourn the meeting if needed to solicit additional proxies to approve the merger agreement.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. EXACT Sciences Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on February 20, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260220:nNDL1kcwQG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4548","BK4139","LU0266013472.USD","BK4585","EXAS","LU1861558580.USD","LU2324357040.USD","BK4588","LU1861559042.SGD"],"gpt_icon":0},{"id":"2613979212","title":"Exact Sciences shareholders approve acquisition by Abbott","url":"https://stock-news.laohu8.com/highlight/detail?id=2613979212","media":"TIPRANKS","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613979212?lang=en_us&edition=fundamental","pubTime":"2026-02-21 05:10","pubTimestamp":1771621853,"startTime":"0","endTime":"0","summary":"Exact Sciences (EXAS) announced that its stockholders voted to approve the proposed acquisition of Exact Sciences by Abbott (ABT) at the special me...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/exact-sciences-shareholders-approve-acquisition-by-abbott-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/exact-sciences-shareholders-approve-acquisition-by-abbott-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2237957902.USD","LU1057294990.SGD","LU1061106388.HKD","LU1989763690.USD","BK4566","LU0868494617.USD","LU0234572021.USD","LU2112291526.USD","BK4585","SG9999004303.SGD","BK4588","ABT","LU0882574055.USD","BK4504","LU1914381329.SGD","EXAS","BK4533","IE0009355771.USD","LU1861559042.SGD","IE00BJT1NW94.SGD","LU1861558580.USD","LU0122379950.USD","LU2089984988.USD","SGXZ23171101.USD","LU2237957811.SGD","SG9999002232.USD","LU1691799644.USD","LU2324357040.USD","IE00BJJMRZ35.SGD","LU0058720904.USD","BK4592","SG9999002224.SGD","LU1989763427.SGD","LU2133065610.SGD","BK4548","IE00B2B36J28.USD","LU2468319806.SGD","LU1721429402.USD","LU0170899867.USD","IE00B4R5TH58.HKD","BK4139","LU1721429741.USD","BK4568","LU2211815571.USD","IE0002141913.USD","BK4082","LU0266013472.USD","SGXZ41872573.SGD","LU1023059063.AUD","IE00BFTCPJ56.SGD"],"gpt_icon":0},{"id":"2613297382","title":"Abbott posts FY 2025 COVID-19 testing-related sales of USD 297 million, down 60.2%","url":"https://stock-news.laohu8.com/highlight/detail?id=2613297382","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613297382?lang=en_us&edition=fundamental","pubTime":"2026-02-21 05:06","pubTimestamp":1771621612,"startTime":"0","endTime":"0","summary":"Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Abbott Laboratories published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on February 20, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260220:nNDL9GwM5x:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1989763690.USD","LU1861559042.SGD","IE0009355771.USD","LU2211815571.USD","LU2133065610.SGD","BK4585","IE00BJJMRZ35.SGD","BK4581","BK4566","LU0114720955.EUR","LU2237957811.SGD","SGXZ41872573.SGD","LU2324357040.USD","SG9999002232.USD","LU1914381329.SGD","IE0002141913.USD","LU1023059063.AUD","BK4504","LU2112291526.USD","SG9999004303.SGD","LU0266013472.USD","LU1057294990.SGD","LU1861558580.USD","IE00BJT1NW94.SGD","LU0882574055.USD","BK4592","LU0170899867.USD","IE00BFTCPJ56.SGD","LU0289739699.SGD","LU1691799644.USD","SGXZ23171101.USD","BK4533","LU1721429741.USD","LU1721429402.USD","BK4568","LU1989763427.SGD","ABT","LU2237957902.USD","BK4548","IE00B2B36J28.USD","LU0058720904.USD","LU2089984988.USD","SG9999002224.SGD","BK4588","LU0234572021.USD","EXAS","LU1061106388.HKD","BK4139","BK4082","IE00B4R5TH58.HKD"],"gpt_icon":0},{"id":"2613297845","title":"Exact Sciences Corp - Deal Expected to Close Before End of Q2 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2613297845","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613297845?lang=en_us&edition=fundamental","pubTime":"2026-02-21 05:05","pubTimestamp":1771621500,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260220:nTUA8THBKS:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0170899867.USD","LU1861558580.USD","LU2237957811.SGD","LU2133065610.SGD","BK4504","SG9999002224.SGD","IE00B4R5TH58.HKD","IE0009355771.USD","EXAS","LU2112291526.USD","LU2237957902.USD","LU1914381329.SGD","LU0868494617.USD","SGXZ23171101.USD","LU0289739699.SGD","IE00BFTCPJ56.SGD","BK4548","LU0058720904.USD","LU1057294990.SGD","IE00B2B36J28.USD","LU1061106388.HKD","SG9999002232.USD","IE0002141913.USD","ABT","SG9999004303.SGD","LU1989763690.USD","LU1023059063.AUD","BK4139","LU0266013472.USD","IE00BJT1NW94.SGD","SGXZ41872573.SGD","LU1691799644.USD","LU2089984988.USD","LU1989763427.SGD","BK4585","BK4592","LU0122379950.USD","BK4568","LU0234572021.USD","LU0114720955.EUR","LU2211815571.USD","LU2468319806.SGD","IE00BJJMRZ35.SGD","LU0882574055.USD","BK4082","BK4566","BK4533","LU2324357040.USD","LU1721429741.USD","LU1721429402.USD"],"gpt_icon":0},{"id":"2613429782","title":"Press Release: Exact Sciences Stockholders Approve Acquisition by Abbott","url":"https://stock-news.laohu8.com/highlight/detail?id=2613429782","media":"Dow Jones","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613429782?lang=en_us&edition=fundamental","pubTime":"2026-02-21 05:05","pubTimestamp":1771621500,"startTime":"0","endTime":"0","summary":"Exact Sciences Corporation  , a leading provider of cancer screening and diagnostic tests, today announced that its stockholders voted to approve the proposed acquisition of Exact Sciences by Abbott  at the special meeting of stockholders held earlier today.At the special meeting, preliminary results showed that more than 99% of the votes cast, representing approximately 67% of the total outstanding shares of Exact Sciences common stock as of the January 9, 2026 record date for the special meeting, were voted in favor of the transaction. Final voting results from the special meeting will be reported by Exact Sciences in a Current Report on Form 8--K filed with the U.S. Securities and Exchange Commission .Subject to the satisfaction or waiver of the remaining conditions to closing, the transaction is expected to close before the end of the second calendar quarter of 2026. Under the terms of the definitive agreement with Abbott, upon completion of the transaction, Exact Sciences' stockho","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4592","LU1989763427.SGD","LU0170899867.USD","IE00B2B36J28.USD","EXAS","LU2237957811.SGD","LU0058720904.USD","BK4548","LU0266013472.USD","LU0868494617.USD","LU1691799644.USD","BK4585","BK4232","SG9999004303.SGD","BK4082","LU1061106388.HKD","LU1861558580.USD","LU2112291526.USD","LU1721429402.USD","BK4504","LU2468319806.SGD","BK4566","IE0002141913.USD","LU1023059063.AUD","IE0009355771.USD","BK4568","LU2211815571.USD","LU0114720955.EUR","LU0234572021.USD","LU1057294990.SGD","SG9999002232.USD","ABT","LU1721429741.USD","LU2237957902.USD","BK4581","BK4588","LU0122379950.USD","LU2089984988.USD","LU2133065610.SGD","R","LU0882574055.USD","LU1914381329.SGD","LU2324357040.USD","SG9999002224.SGD","SGXZ41872573.SGD","SGXZ23171101.USD","LU1861559042.SGD","IE00BJT1NW94.SGD","IE00BJJMRZ35.SGD","IE00BFTCPJ56.SGD"],"gpt_icon":0},{"id":"2612545426","title":"Analysts Offer Insights on Healthcare Companies: Exact Sciences (EXAS), HeartFlow, Inc. (HTFL) and Pelthos Therapeutics (PTHS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2612545426","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612545426?lang=en_us&edition=fundamental","pubTime":"2026-02-17 20:30","pubTimestamp":1771331430,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Exact Sciences (EXAS – Research Report), HeartFlow, Inc. (HTFL – ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-exact-sciences-exas-heartflow-inc-htfl-and-pelthos-therapeutics-pths-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-exact-sciences-exas-heartflow-inc-htfl-and-pelthos-therapeutics-pths-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HCSG","LU0128526141.USD","LU0266013472.USD","XLV","BK4585","BK4167","EXAS","BK4548","XBI","LABU","BK4137","BK4588","BK4139","LU1861558580.USD","LU1861559042.SGD","BK4581","HTFL","LU0029874061.USD","PTHS","LU2324357040.USD"],"gpt_icon":0},{"id":"2611912346","title":"Exact Sciences Faces Rising Operational Risk and Strategic Constraints Amid Pending Abbott Merger","url":"https://stock-news.laohu8.com/highlight/detail?id=2611912346","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2611912346?lang=en_us&edition=fundamental","pubTime":"2026-02-15 14:01","pubTimestamp":1771135317,"startTime":"0","endTime":"0","summary":"Exact Sciences Corp (EXAS) has disclosed a new risk, in the Corporate Activity and Growth category. Exact Sciences Corp faces elevated operational ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/exact-sciences-faces-rising-operational-risk-and-strategic-constraints-amid-pending-abbott-merger?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/exact-sciences-faces-rising-operational-risk-and-strategic-constraints-amid-pending-abbott-merger?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2468319806.SGD","BK4533","LU0266013472.USD","BK4588","LU2237957811.SGD","IE00B2B36J28.USD","LU1721429402.USD","IE00B4R5TH58.HKD","BK4504","IE00BJT1NW94.SGD","LU2237957902.USD","BK4585","ABT","LU1989763427.SGD","IE0002141913.USD","LU1861559042.SGD","LU0882574055.USD","SGXZ41872573.SGD","LU1861558580.USD","LU0114720955.EUR","LU1914381329.SGD","LU2112291526.USD","BK4566","LU1061106388.HKD","IE00BFTCPJ56.SGD","LU0122379950.USD","LU0868494617.USD","LU2211815571.USD","BK4581","BK4139","LU1691799644.USD","LU1721429741.USD","LU1989763690.USD","LU2133065610.SGD","LU0289739699.SGD","SGXZ23171101.USD","LU0170899867.USD","LU1057294990.SGD","LU0234572021.USD","BK4592","EXAS","LU2324357040.USD","IE0009355771.USD","BK4548","BK4082","IE00BJJMRZ35.SGD","BK4568","SG9999002232.USD","LU0058720904.USD","LU2089984988.USD"],"gpt_icon":0},{"id":"1197510620","title":"Soros Fund Management's Q4 Portfolio Shifts: Trims Snowflake, Boosts Microsoft and NVIDIA, Initiates Gold Position","url":"https://stock-news.laohu8.com/highlight/detail?id=1197510620","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1197510620?lang=en_us&edition=fundamental","pubTime":"2026-02-14 10:08","pubTimestamp":1771034938,"startTime":"0","endTime":"0","summary":"Soros Fund Management executed notable adjustments to its investment portfolio in the fourth quarter, according to the latest 13F filing. The fund's strategy focused on increasing exposure to major...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"df828bbc181f8e531b7aa463885d2682","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2452424414.USD","LU1803068623.USD","IE0004091025.USD","LU0719512351.SGD","LU0211328371.USD","LU2249611893.SGD","LU0348723411.USD","LU2237443549.SGD","LU2471134796.USD","LU0545039389.USD","GB00BDT5M118.USD","BK4527","LU0943347566.SGD","IE00BHPRN162.USD","LU1116320737.USD","LU2125154778.USD","LU0949170426.SGD","LU1935042488.USD","LU0788109477.HKD","LU0889565833.HKD","LU2750360641.GBP","LU0154236417.USD","LU2097829019.USD","LU2720916845.USD","LU0310800379.SGD","IE00B3SWFQ91.USD","XEL","LU0061474960.USD","LU0823421416.USD","MSFX","LU2473716301.USD","LU2361045086.USD","LU2471134523.USD","LU1989773731.SGD","LU0994945656.USD","SG9999004303.SGD","LU0080751232.USD","LU2272731782.SGD","IE00BKPKM429.USD","MSFD","LU1121112475.USD","SGXZ23171101.USD","LU0965509101.SGD","LU0708994859.HKD","LU1935042991.SGD","LU1032466523.USD","LU1280957306.USD","LU1670710661.SGD","LU0096362180.USD","NVDU","LU1066051811.HKD","IE00BJTD4N35.SGD","LU0353189763.USD","LU2322448791.USD","BK4567","LU2362540622.SGD","BK4576","LU1564329628.SGD","LU1221951129.SGD","LU2028103732.USD","2NVD.UK","LU1670711040.USD","LU0957791311.USD","NVDL","BK4548","LU0345774631.USD","LU0323240290.USD","SNOW","LU1261432733.SGD","LU1989764748.USD","LU1804176565.USD","LU0079474960.USD","LU0786609619.USD","BK4505","SG9999018857.SGD","LU2347655156.SGD","IE00BN8TJ469.HKD","LU1564329032.USD","IE00B3M56506.USD","LU0708995401.HKD","BK4551","LU0960925559.SGD","LU2168564149.EUR","LU1989772840.SGD","LU1069347547.HKD","LU2403377893.USD","LU2077746001.SGD","LU2237438978.USD","LU2265009873.SGD","LU0965509283.SGD","LU1914381329.SGD","LU0251132253.USD","LU1712237335.SGD","LU1992135399.USD","LU0784384876.USD","SG9999014906.USD","LU2404859741.USD","LU1642822529.SGD","LU0949170772.SGD","LU0957808578.USD","LU2404859667.USD","LU2148611432.USD","LU1629891620.HKD","LU2347655073.USD","LU1868837136.USD","LU2065170008.USD","LU0689626769.HKD","NVD3.UK","LU0553294199.USD","LU2191332357.HKD","LU0006306889.USD","LU1585245621.USD","LU0868494617.USD","LU0072462426.USD","LU0149725797.USD","NVD","SGXZ99366536.SGD","LU1815333072.USD","NVII","BK4525","LU1119994496.HKD","BK4559","LU0048584097.USD","LU1868837300.USD","LU1923622614.USD","HK0000320223.HKD","LU1316542783.SGD","LU0070217475.USD","BK4585","LU2023250843.SGD","LU2764263203.CNY","LU1691799644.USD","LU1551013342.USD","NVIW.SI","BK4566","LU0210536198.USD","LU2125909593.SGD","LU1951198990.SGD","LU0215105999.USD","LU2381873111.SGD","LU2357305700.SGD","LU0871640123.AUD","LU2092937221.SGD","LU0757359954.USD","LU0642271901.SGD","LU1989763005.USD","SG9999015358.SGD","LU0390134368.USD","IE0034235303.USD","LU1066053197.SGD","BK4588","LU0256863811.USD","LU0726765562.USD","LU1267930573.SGD","LU1235294995.USD","LU0354030438.USD","SG9999001424.SGD","LU0289739343.SGD","HK0000306701.USD","LU1043141396.HKD","LU1496350171.SGD","MSFY","IE00BZ1G4Q59.USD","LU0345768153.USD","BK4554","LU0234572021.USD","LU2211815571.USD","LU2413666699.HKD","BK4613","LU0757359368.USD","SG9999015952.SGD","LU1852331112.SGD","LU1228905540.USD","LU2756315318.SGD","LU0672654240.SGD","LU1232071149.USD","SG9999015978.USD","IE00BFSS8Q28.SGD","IE00B775SV38.USD","LU0302445910.USD","LU1720051017.SGD","BK4608","IE00BQXX3D17.EUR","LU0476273544.USD","LU1923622291.USD","LU2111349929.HKD","IE000YTNTUN2.SGD","LU1720051108.HKD","LU0162691827.USD","LU1323610961.USD","LU1670710588.SGD","LU1732800096.USD","LU2065169927.USD","LU2746668974.SGD","LU0266013472.USD","LU1935043536.SGD","LU2326559502.SGD","LU0234570918.USD","LU0690374961.EUR","LU0823417653.USD","HK0000306685.HKD","LU0171293334.USD","LU0795875169.SGD","IE00BZ199S13.USD","LU1145028129.USD","BK4532","BK4605","LU0690374615.EUR","LU2264538146.SGD","LU1548497426.USD","LU0082616367.USD","IE00BJTD4V19.USD","LU0095938881.EUR","NVDG","3NVD.UK","SNVD.UK","BK4587","LU0057025933.USD","LU0109391861.USD","LU0314106906.USD","LU0274383776.USD","LU2087625088.SGD","GB00B4QBRK32.GBP","LU0225283273.USD","LU1551013425.SGD","IE00BD6J9T35.USD","IE00B19Z8X17.USD","LU2106854487.HKD","LU2244417387.USD","LU0267386448.USD","LU0964807845.USD","LU0353189680.USD","LU0985320562.USD","LU2462157665.USD","LU1074936037.SGD","LU0210533765.USD","LU2491049909.HKD","LU0345769631.USD","IE00B19Z8W00.USD","LU2506952097.USD","LU0689472784.USD","LU1435385759.SGD","LU1153585028.USD","LU1670711123.USD","LU2506951958.HKD","LU2236285917.USD","LU1674673428.USD","LU1791710582.SGD","LU2125909916.SGD","LU0784385170.HKD","NVDA","LU2108987350.USD","LU1244550221.USD","MSFL","BK4598","BK4503","LU0081259029.USD","IE00BLSP4239.USD","LU2168564065.EUR","LU2168564495.EUR","LU0310799852.SGD","IE00BK4W5M84.HKD","LU1582987324.SGD","LU0107464264.USD","LU0823414478.USD","SGXZ31699556.SGD","SG9999014898.SGD","LU1989764664.SGD","IE00B1XK9C88.USD","LU0053666078.USD","BK4612","LU1046421795.USD","LU1989772923.USD","LU0823421333.USD","LU0345770993.USD","LU2931357623.SGD","SG9999014880.SGD","LU0557290698.USD","LU1069344957.HKD","LU0868494708.USD","IE00B4JS1V06.HKD","IE00B4YYXB79.USD","LU1196500208.SGD","IE0003U64NQ7.SGD","IE0004445015.USD","LU0289960550.SGD","LU1823568750.SGD","LU0289961442.SGD","IE00B775H168.HKD","LU1721428933.USD","LU2125909247.SGD","MSFO","IE00BSNM7G36.USD","LU1571399168.USD","LU2461242641.AUD","LU2463028550.USD","NVDW","LU0724617625.USD","LU1582986433.USD","NVDS","LU2471134952.CNY","LU1235295455.SGD","LU0792757196.USD","LU1697837992.HKD","LU1839511570.USD","LU1366333091.USD","LU2168564222.USD","LU1244550577.SGD","LU0061475181.USD","LU1935042215.USD","LU0347712357.USD","LU1430594728.SGD","LU0203201768.USD","IE0004445239.USD","SG9999015986.USD","LU2083900584.USD","IE000ITXATA3.USD","IE00BFXG0V08.USD","LU1935043023.USD","NVDS.UK","LU2746668461.USD","LU2041044095.USD","LU0029864427.USD","LU2506951792.HKD","LU2092937148.SGD","IE00BDRTCR15.USD","BK4116","LU2125154935.USD","LU0820561909.HKD","LU2279689827.SGD","BK4592","IE00BMPRXR70.SGD","SG9999015945.SGD","LU1699723380.USD","HK0000914686.HKD","LU1992135472.HKD","LU2360107168.USD","LU0011850046.USD","LU0784385840.USD","LU1116320901.HKD","LU1670627923.USD","IE00BQXX3F31.USD","LU0157215616.USD","LU1340139317.AUD","LU2237957902.USD","LU0127658192.USD","LU0472753341.HKD","LU2210149790.SGD","IE00BYQQ9H92.USD","LU1066051225.USD","LU2750360997.AUD","LU1821325948.USD","LU0056508442.USD","LU2092627202.USD","LU0276348264.USD","LU2237443895.HKD","SG9999014567.USD","IE0005OL40V9.USD","LU2063271972.USD","BK4529","IE00BMPRXN33.USD","CRCL","IE0004086264.USD","LU0198837287.USD","LU0265550946.USD","LU0211327993.USD","LU0820562030.AUD","HK0000320264.USD","LU0545562505.USD","LU0466842654.USD","LU0494093205.USD","LU1778281490.HKD","LU0345774391.USD","SG9999015341.SGD","LU1429558221.USD","LU2592432038.USD","LU0316494557.USD","LU1037948897.HKD","LU1236620834.HKD","LU1791710400.SGD","DBRG","LU1242518931.SGD","LU2487616109.SGD","IE00B5949003.HKD","LU0823414551.USD","LU0323591593.USD","LU2360108059.USD","LU1917777945.USD","LU0784383803.USD","IE00BN29S564.USD","IE0001KFT4U8.USD","LU2125909759.SGD","SGXZ51526630.SGD","LU1582986359.USD","LU2210150020.SGD","NGD","IE00BMPRXQ63.HKD","BK4533","IE00BWXC8680.SGD","LU0256863902.USD","LU2458330243.SGD","LU2360032135.SGD","LU1923623000.USD","LU2860962120.EUR","LU0077335932.USD","LU0979878070.USD","LU0345770308.USD","LU2360106780.USD","NVDX","LU0965508806.USD","LU0882574139.USD","LU1868836914.USD","BK4097","LU2505996509.AUD","LU0640476718.USD","LU1221951046.USD","LU2322448957.HKD","LU1035775433.USD","LU1127390331.HKD","LU2065171311.SGD","LU1815336760.USD","BK4607","LU1732799900.SGD","IE00B3S45H60.SGD","LU1084165304.USD","LU1242518857.USD","LU1267930730.SGD","LU2242649171.HKD","LU1988902786.USD","LU1003077747.HKD","LU0456855351.SGD","BK4141","OWL","LU2362541513.USD","SG9999017495.SGD","LU0823434740.USD","LU2417539215.USD","LU2430703178.SGD","LU2361044865.SGD","LU1674673691.USD","LU0210528500.USD","SG9999001077.SGD","IE0009356076.USD","LU2413666426.HKD","LU2430703095.HKD","LU2065171402.SGD","LU0314104364.USD","LU0861579265.USD","LU0661504455.SGD","LU1934455194.USD","LU2023251221.USD","HK0000914660.USD","LU1188199696.SGD","LU2247934214.USD","LU1868836591.USD","LU2491050154.USD","LU0912757837.SGD","LU1974910355.USD","LU0096364046.USD","IE00B5TLWC47.USD","LU0738911758.USD","LU2506951875.HKD","IE00B19Z9505.USD","LU1035773651.USD","LU2089283258.USD","IE00BBT3K403.USD","IE00BKVL7J92.USD","LU0124676726.USD","LU2272731600.USD","LU2237443465.HKD","LU0823417737.USD","LU1582987597.SGD","LU2433249047.HKD","LU1564329461.SGD","SGXZ81514606.USD","IE00BJLML261.HKD","DIPS","LU0511384066.AUD","LU2237443978.SGD","LU2458330169.SGD","LU0342679015.USD","LU0203202063.USD","LU1267930490.SGD","NVDY","LU2764262908.HKD","IE000W1ABFV2.USD","SG9999002232.USD","LU2543165471.USD","LU2242650005.HKD","BK4614","LU2362541273.HKD","LU0170899867.USD","IE0034235188.USD","BK4516","BK4538","LU0942090050.USD","LU2097344357.USD","NVDD","LU2087621335.USD","LU2896262040.SGD","LU1496350502.SGD","LU0820561818.USD","LU1934455277.USD","IE000KEQY171.SGD","LU0795875086.SGD","LU1066051498.USD","LU1623119135.USD","LU0426417589.USD","LU2097344431.USD","LU2290526834.HKD","NVDQ","SG9999018865.SGD","IE00B7KXQ091.USD","SG9999014914.USD","LU2456880835.USD","LU0528227936.USD","LU2054465674.USD","LU0889566641.SGD","IBKR","LU0109392836.USD","LU0426412945.USD","LU1861215975.USD","BK4528","LU2420271590.USD","LU2294711713.HKD","BK4535","LU2095319765.USD","LU0894485498.HKD","LU0345768740.USD","LU2023250504.SGD","LU1032955483.USD","BK4550","LU2213496289.HKD","LU2552382058.USD","LU2286300806.USD","BK4581","LU2361044949.HKD","LU0312595415.SGD","GB00B4LPDJ14.GBP","SG9999014575.USD","LU0444971666.USD","LU2430703251.USD","LU1868836757.USD","LU1236620750.USD","IE00BLSP4452.SGD","BK4549","LU1814569148.SGD","IE0009G5SDU7.USD","BK4504","LU0823434583.USD","BK4577","MSFW","LU0320765059.SGD","LU1366192091.USD","LU2089284900.SGD","MSFT","LU1670628061.USD","LU2491050071.SGD","LU1861220033.SGD","LU2471134879.HKD","IE00BFSS7M15.SGD","BK4543","LU0323239441.USD","LU0097036916.USD","LU1228905037.USD","LU0158827781.USD","LU2023250330.USD","LU0308772762.SGD","LU2237443382.USD","LU2357125470.USD","LU0417517546.SGD","LU0061474705.USD","LU0879622024.SGD","IE00BJJMRX11.SGD","LU0345769128.USD","LU2756315664.SGD","LU0187121727.USD","EXAS","SG9999014559.SGD","MSFU","LU2089985449.USD","SG9999002224.SGD","NVD2.UK","LU0787776722.HKD","LU2168563687.JPY","LU2237443622.USD","IE0034235295.USD","LU2506952170.USD","LU2602419157.SGD","SG9999014542.SGD","LU0106261372.USD","LU0175139822.USD","IE00BJJMRY28.SGD","LU0158827948.USD","LU1244550494.USD","LU0894486033.HKD","LU2298321311.HKD","LU1633808545.USD","LU1043141123.HKD","BK4579","LU1181866309.USD","LU0265550359.USD","LU2133065610.SGD","LU1506573853.SGD","IE00BK4W5L77.USD","LU0444973449.USD","LU0072461881.USD","LU2552382215.SGD","LU2271345857.HKD","LU0965509010.AUD","LU2552382132.HKD","IE00B1BXHZ80.USD","LU0683600562.USD","LU1983260115.SGD","LU2250418816.HKD","LU1564329115.USD","LU0238689110.USD","LU1934455863.HKD","LU0094547139.USD","LU0950375773.USD","IE00BDCRKT87.USD","LU1301847155.USD","LU2764263039.SGD","LU0354030511.USD","LU1861127337.USD","LU2275660780.HKD","LU2272731865.HKD","LU2237957811.SGD","LU0128525929.USD","LU1951200564.SGD","LU2505996681.GBP","LU1064131342.USD","LU1803068979.SGD","SG9999000418.SGD","LU1718418525.SGD","LU0069063385.USD","LU1059921491.USD","IE00BYXW3230.USD","IE00BQXX3C00.GBP","BK4534","LU1267930813.SGD","LU0289941410.SGD","IE00BKDWB100.SGD","LU1334329650.SGD","LU1037948541.HKD"],"gpt_icon":1},{"id":"2611019382","title":"Cancer diagnostics firm Exact Sciences' Q4 revenue rises","url":"https://stock-news.laohu8.com/highlight/detail?id=2611019382","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2611019382?lang=en_us&edition=fundamental","pubTime":"2026-02-14 05:14","pubTimestamp":1771017296,"startTime":"0","endTime":"0","summary":"Cancer diagnostics firm Exact Sciences' Q4 revenue risesOverviewCancer screening firm's Q4 revenue rose 23%, beating analyst expectationsAdjusted EBITDA for Q4 was $63 mln, affected by $75 mln R&D exp","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260213:nL1N3Z9175:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","EXAS","LU1861559042.SGD","BK4139","BK4548","LU0266013472.USD","LU2324357040.USD","BK4585","LU1861558580.USD"],"gpt_icon":0},{"id":"2611193328","title":"Exact Sciences Q4 Loss Narrows, Revenue Rises","url":"https://stock-news.laohu8.com/highlight/detail?id=2611193328","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2611193328?lang=en_us&edition=fundamental","pubTime":"2026-02-14 05:14","pubTimestamp":1771017285,"startTime":"0","endTime":"0","summary":"Exact Sciences  reported a Q4 net loss late Friday of $0.45 per diluted share, narrowing from a loss of $4.67 a year earlier.Analysts polled by FactSet expected a loss of $0.11.Revenue in the three months ended Dec. 31 rose to $878.4 million from $713.4 million a year earlier.Analysts polled by FactSet expected $860.9 million.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["EXAS"],"gpt_icon":0},{"id":"2611819363","title":"Exact Sciences reports Q4 EPS (45c) vs (27c) last year","url":"https://stock-news.laohu8.com/highlight/detail?id=2611819363","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2611819363?lang=en_us&edition=fundamental","pubTime":"2026-02-14 05:10","pubTimestamp":1771017032,"startTime":"0","endTime":"0","summary":"Reports Q4 revenue $878M, consensus $860.76M. “In 2025 the Exact Sciences (EXAS) team delivered on our mission by screening more people than ever b...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/exact-sciences-reports-q4-eps-45c-vs-27c-last-year-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/exact-sciences-reports-q4-eps-45c-vs-27c-last-year-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["EXAS"],"gpt_icon":0},{"id":"2611198709","title":"Exact Sciences Q4 free cash flow surges nearly fivefold to USD 357 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2611198709","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2611198709?lang=en_us&edition=fundamental","pubTime":"2026-02-14 05:05","pubTimestamp":1771016756,"startTime":"0","endTime":"0","summary":"Exact Sciences Corporation reported record financial results for the fourth quarter  and full year  2025. Total revenue for Q4 2025 reached USD 878 million, representing a 23 percent increase. Screening revenue for the quarter was USD 695 million, while Precision Oncology revenue totaled USD 183 million. For the full year 2025, total revenue was USD 3.25 billion, up 18 percent. Screening revenue contributed USD 2.53 billion, and Precision Oncology revenue was USD 717 million. Operating cash flow for FY 2025 was USD 491 million, and free cash flow stood at USD 357 million, marking a multiple increase compared to the previous year. The company reported a net loss of USD 208 million for FY 2025. Adjusted EBITDA for the year was USD 400 million, with an adjusted EBITDA margin of 12 percent. Product and corporate highlights for the period include the recognition of USD 7.5 million in sublicense revenue under a new agreement executed in Q2 2025, related to technology licensed from TwinStrand","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260213:nNDL9ytd7m:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4548","BK4139","LU2324357040.USD","LU1861558580.USD","LU1861559042.SGD","BK4588","LU0266013472.USD","EXAS"],"gpt_icon":0},{"id":"2611198726","title":"BRIEF-Exact Sciences Q4 Basic EPS USD -0.45","url":"https://stock-news.laohu8.com/highlight/detail?id=2611198726","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2611198726?lang=en_us&edition=fundamental","pubTime":"2026-02-14 05:05","pubTimestamp":1771016746,"startTime":"0","endTime":"0","summary":"BRIEF-Exact Sciences Q4 Basic EPS USD -0.45\n\n\nFeb 13 (Reuters) - Exact Sciences Q4 revenue USD 878.381 million vs. IBES estimate USD 860.9 million.\n\nQ4 pretax profit USD -85.083 million\nQ4 income from operations USD -82.595 million\nQ4 net income USD -85.955 million","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260213:nPLX5BF5D2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4548","BK4139","LU2324357040.USD","LU1861558580.USD","LU1861559042.SGD","BK4588","LU0266013472.USD","EXAS"],"gpt_icon":0},{"id":"2611198743","title":"Exact Sciences Q4 Net Income USD -85.955 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2611198743","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2611198743?lang=en_us&edition=fundamental","pubTime":"2026-02-14 05:05","pubTimestamp":1771016702,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260213:nPLX5BF5D2:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0266013472.USD","LU1861558580.USD","BK4548","BK4588","LU1861559042.SGD","EXAS","BK4585","BK4139","LU2324357040.USD"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.exactsciences.com","stockEarnings":[{"period":"1week","weight":-0.001},{"period":"1month","weight":0.0008},{"period":"3month","weight":0.0201},{"period":"6month","weight":0.9169},{"period":"1year","weight":1.2532},{"period":"ytd","weight":0.0181}],"compareEarnings":[{"period":"1week","weight":-0.0128},{"period":"1month","weight":-0.0254},{"period":"3month","weight":-0.0186},{"period":"6month","weight":0.0288},{"period":"1year","weight":0.2166},{"period":"ytd","weight":-0.0082}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX Breast Recurrence Score Test; Oncotype DX Breast DCIS Score Test; Oncotype DX Colon Recurrence Score Test; OncoExTra Test for tumor profiling for patients with advanced, metastatic, refractory, relapsed, or recurrent cancer; and Covid-19 testing services. The company's pipeline products focus on enhancing the Cologuard test's performance characteristics and developing blood and other fluid-based tests. It has license agreements with MAYO Foundation for Medical Education and Research, and Johns Hopkins University. Exact Sciences Corporation was incorporated in 1995 and is headquartered in Madison, Wisconsin.","yearOnYearQuotes":[{"month":1,"riseRate":0.52,"avgChangeRate":0.086734},{"month":2,"riseRate":0.307692,"avgChangeRate":-0.063077},{"month":3,"riseRate":0.576923,"avgChangeRate":0.067646},{"month":4,"riseRate":0.44,"avgChangeRate":0.019298},{"month":5,"riseRate":0.56,"avgChangeRate":0.062822},{"month":6,"riseRate":0.6,"avgChangeRate":0.087593},{"month":7,"riseRate":0.36,"avgChangeRate":-0.017914},{"month":8,"riseRate":0.44,"avgChangeRate":0.011727},{"month":9,"riseRate":0.52,"avgChangeRate":0.004142},{"month":10,"riseRate":0.36,"avgChangeRate":-0.033378},{"month":11,"riseRate":0.6,"avgChangeRate":0.038195},{"month":12,"riseRate":0.6,"avgChangeRate":0.05429}],"exchange":"NASDAQ","name":"Exact Sciences","nameEN":"Exact Sciences"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Exact Sciences(EXAS),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Exact Sciences(EXAS) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Exact Sciences,EXAS,Exact Sciences股票,Exact Sciences股票老虎,Exact Sciences股票老虎国际,Exact Sciences行情,Exact Sciences股票行情,Exact Sciences股价,Exact Sciences股市,Exact Sciences股票价格,Exact Sciences股票交易,Exact Sciences股票购买,Exact Sciences股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Exact Sciences(EXAS),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Exact Sciences(EXAS) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction